Cargando…

Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection

BACKGROUND: As a member of the tumor necrosis factor receptor (TNFR) protein superfamily, equine lentivirus receptor 1 (ELR1) has been shown to be expressed in various equine cells that are permissive for equine infectious anemia virus (EIAV) replication. The EIAV Tat protein (eTat) activates transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Cheng, Ma, Jian, Liu, Qiang, Li, Yun-Fei, He, Xi-Jun, Lin, Yue-Zhi, Wang, Xue-Feng, Meng, Qing-Wen, Wang, Xiaojun, Zhou, Jian-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422544/
https://www.ncbi.nlm.nih.gov/pubmed/25928027
http://dx.doi.org/10.1186/s12977-015-0163-7
_version_ 1782370070292332544
author Du, Cheng
Ma, Jian
Liu, Qiang
Li, Yun-Fei
He, Xi-Jun
Lin, Yue-Zhi
Wang, Xue-Feng
Meng, Qing-Wen
Wang, Xiaojun
Zhou, Jian-Hua
author_facet Du, Cheng
Ma, Jian
Liu, Qiang
Li, Yun-Fei
He, Xi-Jun
Lin, Yue-Zhi
Wang, Xue-Feng
Meng, Qing-Wen
Wang, Xiaojun
Zhou, Jian-Hua
author_sort Du, Cheng
collection PubMed
description BACKGROUND: As a member of the tumor necrosis factor receptor (TNFR) protein superfamily, equine lentivirus receptor 1 (ELR1) has been shown to be expressed in various equine cells that are permissive for equine infectious anemia virus (EIAV) replication. The EIAV Tat protein (eTat) activates transcription initiated at the viral long terminal repeat (LTR) promoter through a unique mechanism that requires the recruitment of the equine cyclin T1 (eCT1) cofactor into the viral TAR RNA target element. In vitro studies have demonstrated that mouse fibroblast cell lines (e.g., NIH 3T3 cells) that express the EIAV receptor ELR1 and eCT1 support the productive replication of EIAV. Therefore, we constructed transgenic eCT1- and ELR1-expressing mice to examine whether they support in vivo EIAV replication. FINDINGS: For the first time, we constructed mice transgenic for ELR1 and eCT1. Real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis confirmed that ELR1 and eCT1 were expressed in the transgenic mouse tissues, particularly in the intestines, spleen and lymph nodes. Consistent with the results of EIAV infection in NIH 3T3 cells expressing ELR1 and eCT1, mouse embryonic fibroblasts (MEFs) from the transgenic mice could support EIAV replication. More importantly, this virus could infect and replicate in mouse blood monocyte-derived macrophages (mMDMs). Macrophages are the principle target cell of EIAV in its natural hosts. Furthermore, after the transgenic mice were inoculated with EIAV, the virus could be detected not only in the plasma of the circulating blood but also in multiple organs, among which, the spleen and lymph nodes were the predominant sites of EIAV replication. Finally, we found that consistent with high viral replication levels, the relevant pathological changes occurred in the spleen and lymph nodes. CONCLUSIONS: Our results show that mice transgenic for ELR1 and eCT1 are susceptible to EIAV infection and replication. Further, EIAV infection can cause lesions on the spleen and lymph nodes, similar to those frequently observed in horses, the natural hosts. Therefore, ELR1 and eCT1 are essential in vivo for EIAV invasion and replication. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0163-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4422544
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44225442015-05-07 Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection Du, Cheng Ma, Jian Liu, Qiang Li, Yun-Fei He, Xi-Jun Lin, Yue-Zhi Wang, Xue-Feng Meng, Qing-Wen Wang, Xiaojun Zhou, Jian-Hua Retrovirology Short Report BACKGROUND: As a member of the tumor necrosis factor receptor (TNFR) protein superfamily, equine lentivirus receptor 1 (ELR1) has been shown to be expressed in various equine cells that are permissive for equine infectious anemia virus (EIAV) replication. The EIAV Tat protein (eTat) activates transcription initiated at the viral long terminal repeat (LTR) promoter through a unique mechanism that requires the recruitment of the equine cyclin T1 (eCT1) cofactor into the viral TAR RNA target element. In vitro studies have demonstrated that mouse fibroblast cell lines (e.g., NIH 3T3 cells) that express the EIAV receptor ELR1 and eCT1 support the productive replication of EIAV. Therefore, we constructed transgenic eCT1- and ELR1-expressing mice to examine whether they support in vivo EIAV replication. FINDINGS: For the first time, we constructed mice transgenic for ELR1 and eCT1. Real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis confirmed that ELR1 and eCT1 were expressed in the transgenic mouse tissues, particularly in the intestines, spleen and lymph nodes. Consistent with the results of EIAV infection in NIH 3T3 cells expressing ELR1 and eCT1, mouse embryonic fibroblasts (MEFs) from the transgenic mice could support EIAV replication. More importantly, this virus could infect and replicate in mouse blood monocyte-derived macrophages (mMDMs). Macrophages are the principle target cell of EIAV in its natural hosts. Furthermore, after the transgenic mice were inoculated with EIAV, the virus could be detected not only in the plasma of the circulating blood but also in multiple organs, among which, the spleen and lymph nodes were the predominant sites of EIAV replication. Finally, we found that consistent with high viral replication levels, the relevant pathological changes occurred in the spleen and lymph nodes. CONCLUSIONS: Our results show that mice transgenic for ELR1 and eCT1 are susceptible to EIAV infection and replication. Further, EIAV infection can cause lesions on the spleen and lymph nodes, similar to those frequently observed in horses, the natural hosts. Therefore, ELR1 and eCT1 are essential in vivo for EIAV invasion and replication. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0163-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-28 /pmc/articles/PMC4422544/ /pubmed/25928027 http://dx.doi.org/10.1186/s12977-015-0163-7 Text en © Du et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Du, Cheng
Ma, Jian
Liu, Qiang
Li, Yun-Fei
He, Xi-Jun
Lin, Yue-Zhi
Wang, Xue-Feng
Meng, Qing-Wen
Wang, Xiaojun
Zhou, Jian-Hua
Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title_full Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title_fullStr Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title_full_unstemmed Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title_short Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection
title_sort mice transgenic for equine cyclin t1 and elr1 are susceptible to equine infectious anemia virus infection
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422544/
https://www.ncbi.nlm.nih.gov/pubmed/25928027
http://dx.doi.org/10.1186/s12977-015-0163-7
work_keys_str_mv AT ducheng micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT majian micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT liuqiang micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT liyunfei micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT hexijun micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT linyuezhi micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT wangxuefeng micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT mengqingwen micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT wangxiaojun micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection
AT zhoujianhua micetransgenicforequinecyclint1andelr1aresusceptibletoequineinfectiousanemiavirusinfection